UBS Maintains Neutral on eHealth, Lowers Price Target to $7

Benzinga · 05/08 18:58
UBS analyst Jonathan Yong maintains eHealth (NASDAQ:EHTH) with a Neutral and lowers the price target from $9.5 to $7.